Registered Tanzania · TMDA

Dawadur 2.4Mega IU

Benzathine benzyl penicillin 2.4 mega IU

What it does

Benzathine is an antibiotic used to treat various bacterial infections.

Commonly used for: rheumatic fever, syphilis, certain skin infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 24 HM 0510
Registration date
2024-12-17
Expiry date
2029-12-16
Status
Registered/Compliant
Active ingredient
Benzathine benzyl penicillin 2.4 mega IU
Strength
2.4
Pack size
-
Therapeutic class
-
RxNorm RxCUI
1311516
Manufacturer / MAH
Cspc Zhongnuo Pharmaceutical
Applicant / LTR
DAWA Limited
Country of origin
CHINA

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:42:22 · updated 2026-09-17 03:00:43

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About benzathine

Benzathine is an antibiotic used to treat various bacterial infections.

What it treats

  • rheumatic fever
  • syphilis
  • certain skin infections

How it works

Benzathine works by stopping the growth of bacteria in the body.

Who it's for

It is for people who have bacterial infections that require treatment with antibiotics.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About benzyl

Benzyl is an ingredient used in various treatments, often in topical formulations.

What it treats

  • skin infections
  • eczema
  • scabies

How it works

Benzyl helps to kill bacteria or parasites on the skin, promoting healing.

Who it's for

This treatment is for individuals with skin conditions requiring antibacterial or antiparasitic action.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About mega

Mega is a medication used for various health conditions. Please consult your healthcare provider for specific information.

How it works

The exact way Mega works in the body is not specified, but it is designed to help manage certain health issues.

Who it's for

Mega may be prescribed to individuals with specific health conditions, as determined by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About penicillin

Penicillin is an antibiotic used to treat various bacterial infections.

What it treats

  • bacterial infections
  • pneumonia
  • strep throat
  • skin infections

How it works

Penicillin works by stopping the growth of bacteria, helping the body fight off the infection.

Who it's for

It is suitable for people who have bacterial infections that are known to respond to penicillin.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: benzathine

BNF-referenced

Benzathine is a long-acting form of penicillin, primarily used as an antibiotic for the treatment and prevention of various bacterial infections. It is administered via intramuscular injection and is known for its extended duration of action, making it suitable for conditions requiring prolonged antibacterial activity. Its molecular formula is C16H20N2, indicating its structure and composition.

Indications

  • Rheumatic fever prevention
  • Syphilis treatment
  • Streptococcal infections
  • Bacterial endocarditis prophylaxis

Dosage

Children: For children, the recommended dose for rheumatic fever prophylaxis is 600,000 units for those weighing less than 27 kg, and 1.2 million units for those weighing 27 kg or more, administered every 3 to 4 weeks.

Adults: The usual adult dose for the treatment of syphilis is a single intramuscular injection of 2.4 million units. For rheumatic fever prophylaxis, the recommended dose is 1.2 million units every 3 to 4 weeks.

Mechanism of action

Benzathine exerts its antibacterial effect by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) within the bacterial cell wall, leading to cell lysis and death. This mechanism is effective against a wide range of gram-positive bacteria, particularly Streptococcus species.

Pharmacodynamics

The pharmacodynamics of benzathine penicillin involves the drug's ability to maintain therapeutic concentrations in the body for an extended period. The prolonged release from the injection site allows for sustained antibacterial activity, making it effective in treating infections such as rheumatic fever and syphilis. The drug is particularly effective against organisms that are sensitive to penicillin.

Pharmacokinetics

Benzathine is administered intramuscularly, where it is slowly absorbed into the bloodstream. The peak plasma concentrations occur within 12 to 24 hours after administration, with a half-life that can extend up to several days, depending on the dosage and individual patient factors. It is primarily excreted by the kidneys. Due to its long-acting nature, benzathine is suitable for single-dose treatment regimens in certain infections.

Contra-indications

  • Hypersensitivity to benzathine or any component of the formulation
  • Severe allergies to other penicillins or beta-lactam antibiotics

Adverse effects

  • Allergic reactions, including anaphylaxis
  • Rash
  • Fever
  • Angioedema
  • Nausea
  • Vomiting
  • Diarrhea
  • Superinfection with prolonged use

Interactions

  • May have reduced efficacy when administered concurrently with bacteriostatic antibiotics such as tetracyclines
  • Probenecid may increase the serum concentrations of benzathine

Precautions

  • Use with caution in patients with a history of allergies or asthma
  • Monitor for signs of anaphylaxis during and after administration
  • Evaluate renal function in patients receiving high doses or prolonged therapy

Pregnancy

Benzathine is classified as category B. Animal studies have shown no harm; however, adequate and well-controlled studies in pregnant women are lacking.

Breast-feeding

Benzathine is excreted in breast milk. Caution is recommended when administering to breastfeeding mothers.

Storage

Store in a cool, dry place, away from light. Do not freeze.

Formulations

  • Benzathine benzylpenicillin injection
  • Benzathine penicillin G suspension

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: benzyl

BNF-referenced

Benzylpenicillin, a member of the penicillin class of antibiotics, is primarily used to treat infections caused by susceptible microorganisms. It is effective against a range of Gram-positive bacteria and some Gram-negative bacteria, making it a valuable agent in the treatment of various infections, including pneumonia, meningitis, and syphilis.

Indications

  • Bacterial infections
  • Pneumonia
  • Meningitis
  • Syphilis
  • Endocarditis
  • Skin and soft tissue infections

Dosage

Children: Paediatric dosing for benzylpenicillin is determined by the child's weight and the severity of the infection. Refer to the BNF for Children for specific dosing guidelines.

Adults: The usual adult dose for benzylpenicillin varies based on the type and severity of the infection. It is generally administered via intramuscular or intravenous routes. For severe infections, doses may range from 1 to 4 million units every 4 to 6 hours.

Mechanism of action

Benzylpenicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the transpeptidation process, which is crucial for cross-linking peptidoglycan layers. This inhibition leads to cell lysis and death of the bacteria.

Pharmacodynamics

Benzylpenicillin demonstrates time-dependent bactericidal activity, meaning its effectiveness is related to the duration of time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target bacteria. It has a narrow spectrum of activity, primarily targeting Gram-positive cocci and some Gram-negative rods.

Pharmacokinetics

Benzylpenicillin is typically administered parenterally due to poor oral absorption. It is rapidly distributed throughout the body and can penetrate various tissues, including the central nervous system during inflammation. The drug is primarily eliminated by renal excretion, with a half-life of approximately 30 minutes to 1 hour in healthy individuals. Dosage adjustments may be necessary in patients with renal impairment.

Interactions

  • leflunomide+benzylpenicillin: Unknown (increases exposure)
  • nitisinone+benzylpenicillin: Unknown (increases exposure)
  • teriflunomide+benzylpenicillin: Unknown (increases exposure)

Pregnancy

Benzylpenicillin is generally considered safe to use during pregnancy, as it is a penicillin antibiotic and has a long history of use.

Breast-feeding

Benzylpenicillin is excreted in breast milk in small amounts, but it is not expected to have adverse effects on a nursing infant.

Storage

Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored in a refrigerator and used within a limited time frame.

Formulations

  • Benzylpenicillin injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: mega

Mega is a term that may refer to various substances, but it is not a specific drug name. In pharmacological contexts, it could relate to formulations or combinations designed for enhanced efficacy. Without specific BNF or PubChem data, it is difficult to provide a precise monograph. Generally, drugs categorized under similar terminologies often aim to improve therapeutic outcomes or pharmacokinetics.

Dosage

Children: Refer to specific drug protocols, as dosing will vary widely depending on the active ingredients and clinical context.

Adults: Refer to specific drug protocols, as dosing will vary widely depending on the active ingredients and clinical context.

Mechanism of action

The mechanism of action for drugs referred to as 'mega' cannot be determined without specific context or substance identification. Typically, such drugs may function by enhancing bioavailability, modifying pharmacokinetics, or combining multiple active ingredients to target different pathways simultaneously.

Pharmacodynamics

Pharmacodynamics will vary significantly based on the specific drug in question. In general, pharmacodynamics examines the biochemical and physiological effects of drugs and their mechanisms of action. For combination therapies, such as those implied by 'mega', the interaction between compounds may lead to synergistic effects, impacting overall therapeutic efficacy.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion of drugs. For a drug classified under 'mega', these parameters will depend on the specific constituents of the formulation. Typical considerations include the route of administration, half-life, volume of distribution, and metabolic pathways, which can influence dosing regimens and therapeutic monitoring.

Pregnancy

Safety during pregnancy has not been established. Use only if potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised as it is not known whether the drug is excreted in human milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: penicillin

BNF-referenced

Penicillin is a group of antibiotics that are widely used to treat bacterial infections. It works by inhibiting the synthesis of bacterial cell walls, leading to cell lysis and death. Penicillin is effective against a variety of gram-positive bacteria and some gram-negative bacteria, making it a cornerstone in the treatment of infections such as pneumonia, streptococcal infections, and syphilis.

Indications

  • Bacterial infections
  • Pneumonia
  • Streptococcal infections
  • Syphilis
  • Meningitis
  • Endocarditis
  • Skin infections

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on the type of penicillin and indication.

Adults: Refer to the BNF for specific dosing recommendations based on the type of penicillin and indication.

Mechanism of action

Penicillin targets penicillin-binding proteins (PBPs) located inside the bacterial cell wall. By binding to these proteins, penicillin disrupts the transpeptidation process, which is essential for cell wall structural integrity. This results in weakened cell walls, causing osmotic instability and ultimately leading to cell lysis and death.

Pharmacodynamics

Penicillin exhibits bactericidal activity, meaning that it kills bacteria rather than merely inhibiting their growth. Its effectiveness is generally dependent on the growth phase of the bacteria, as it is most active against actively dividing cells. The spectrum of activity varies among different penicillins, with some being more effective against specific bacterial strains.

Pharmacokinetics

Penicillin is primarily absorbed in the gastrointestinal tract, with its bioavailability varying depending on the specific type of penicillin. It is primarily excreted by the kidneys, with a half-life that typically ranges from 30 minutes to 2 hours, depending on the formulation. Dosage adjustments may be necessary in patients with renal impairment to prevent accumulation and toxicity.

Contra-indications

  • History of hypersensitivity to penicillins
  • Severe allergic reactions to beta-lactam antibiotics

Adverse effects

  • Allergic reactions such as rash, urticaria, and anaphylaxis
  • Gastrointestinal disturbances including nausea, vomiting, and diarrhea
  • Superinfection due to alteration of normal flora
  • Hematologic reactions such as leukopenia, thrombocytopenia

Interactions

  • valproate+penicillins: Severe (increases risk of adverse effects)
  • allopurinol+penicillins: Unknown (increases risk of skin rash)
  • leflunomide+penicillins: Unknown (increases exposure)
  • nitisinone+penicillins: Unknown (increases exposure)
  • penicillins+phenindione: Unknown (increases risk of bleeding events)
  • teriflunomide+penicillins: Unknown (increases exposure)

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for signs of allergic reactions
  • Consider alternative therapy in patients with a history of severe allergies

Pregnancy

Penicillins are generally considered safe to use during pregnancy; however, consult local guidelines and assess benefits versus risks.

Breast-feeding

Penicillins are excreted in breast milk in small amounts; generally considered safe, but monitor infant for possible effects.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Oral tablets
  • Oral suspension
  • Intravenous injection
  • Intramuscular injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: benzathine

PubChem CID 8793

Molecular formula: C16H20N2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: benzyl

PubChem CID 123147

Molecular formula: C7H7

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

Molecular reference: penicillin

PubChem CID 2349

Molecular formula: C16H18N2O4S

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.